THOMAS R II STAAB
CIK 1230708 · Chief Financial Officer · last filed 2026-05-13
THOMAS R II STAAB is a Chief Financial Officer who has filed 104 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for TENX, was dated May 13, 2026. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.22M
4
104
-$2.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TENX | Chief Financial Officer | 10,000 | $11.48 | $114.8K | $0 | 1 | 2026-05-13 |
| LNSR | Chief Financial Officer | 174,609 | $5.82 | $1.02M | $8.7K | 13 | 2026-05-08 |
| BCRX | Senior Vice President and CFO | 125,176 | $8.70 | $1.09M | -$2.32M | 71 | 2020-02-25 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | EVP, CFO & Treasurer | 0 | — | — | $0 | 19 | 2011-05-16 |
Recent Filings
104 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-13 | TENX | Grant (A) | +10,000 | $0 | EDGAR |
| 2026-05-08 | LNSR | Tax (F) | −1,350 | -$7.3K | EDGAR |
| 2026-03-19 | LNSR | Exer (M) | +5,500 | $14.6K | EDGAR |
| 2026-02-20 | LNSR | Tax (F) | −1,076 | -$12.2K | EDGAR |
| 2026-01-13 | LNSR | Tax (F) | −1,826 | -$21.1K | EDGAR |
| 2025-02-20 | LNSR | Grant (A) | +12,766 | $0 | EDGAR |
| 2025-02-06 | LNSR | Tax (F) | −1,839 | -$15.2K | EDGAR |
| 2024-08-12 | LNSR | Exer (M) | +3,500 | $9.3K | EDGAR |
| 2024-05-08 | LNSR | Mixed | +17,147 | -$8.2K | EDGAR |
| 2023-01-13 | LNSR | Grant (A) | +6,656 | $0 | EDGAR |